今日药学

2020, v.30(12) 833-836

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

新型冠状病毒肺炎流行期间成人哮喘的治疗建议及患者管理
Treatment Recommendations and Patient Management of Adult Asthma Patients during COVID-19 Epidemic

杨志成;郭素娟;陈爱伦;王南松;
YANG Zhicheng;GUO Sujuan;CHEN Ailun;WANG Nansong;Department of Pharmacy,The University of Hong Kong-Shenzhen Hospital;Department of Respiratory and Critical Care Medicine,The University of Hong Kong-Shenzhen Hospital;

摘要(Abstract):

目的为新型冠状病毒肺炎流行期间哮喘患者的药物治疗及患者管理提供建议,减少患者急性加重风险。方法临床药师参与哮喘门诊工作,为患者制定哮喘行动计划,对新冠疫情期间哮喘患者药物使用和患者管理提供建议。结果临床药师参与的哮喘门诊团队诊疗模式可以协助患者优化治疗方案,强化自我管理,减少患者发生哮喘急性加重的风险。结论临床药师参与哮喘患者的慢病管理过程,能够提高患者自我管理能力,降低患者因疫情出现哮喘控制波动的风险。
OBJECTIVE To provide recommendations for drug treatment and patient management of patients with asthma during the epidemic of Novel Coronavirus Pneumonia(COVID-19) to reduce the risk of acute exacerbations. METHODS Clinical pharmacists participated in the asthma clinic,developed an asthma action plan for patients,and provided advice on medication and patient management during the COVID-19 epidemic. RESULTS The asthma clinic team with clinical pharmacist participation could help patients optimize treatment plans,strengthen self-management,and reduce the risk of acute exacerbation of asthma. CONCLUSION The participation of clinical pharmacists in the chronic disease management process of asthma patients can further improve patients' self-management ability,and also reduce the risk of patients with asthma control fluctuations due to the epidemic.

关键词(KeyWords): 新型冠状病毒肺炎;哮喘管理;药师门诊;哮喘行动计划;慢病管理
COVID-19;asthma management;pharmacy clinic;asthma action plan;chronic disease management

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 杨志成;郭素娟;陈爱伦;王南松;
YANG Zhicheng;GUO Sujuan;CHEN Ailun;WANG Nansong;Department of Pharmacy,The University of Hong Kong-Shenzhen Hospital;Department of Respiratory and Critical Care Medicine,The University of Hong Kong-Shenzhen Hospital;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享